Bristol‑Myers Squibb Announces Dividend Increase

NEW YORK--(BUSINESS WIRE)-- The Board of Directors of Bristol-Myers Squibb Company (NYSE: BMY) today declared a quarterly dividend of forty-five cents ($0.45) per share on the $.10 par value Common Stock of the corporation. The next quarterly dividend will be payable on May 1, 2020, to stockholders of record at the close of business on April 3, 2020.

The directors also declared a quarterly dividend of fifty cents ($0.50) per share on the $2.00 Convertible Preferred Stock of the corporation, payable June 1, 2020 to stockholders of record at the close of business on May 5, 2020.

About Bristol-Myers Squibb

Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. For more information about Bristol-Myers Squibb, visit us at BMS.com or follow us on LinkedIn, Twitter, YouTube, Facebook, and Instagram.

View source version on businesswire.com: https://www.businesswire.com/news/home/20200302005968/en/

Media:
[email protected]
609-252-3345

Investors:
Tim Power, 609-252-7509, [email protected]
Nina Goworek, 908-673-9711, [email protected]

Source: Bristol-Myers Squibb Company

You May Also Be Interested In

• Bristol Myers Squibb Presents Data Up to Five Years Reinforcing the Long-Term Efficacy and Safety of Camzyos (mavacamten) in Symptomatic Obstructive Hypertrophic Cardiomyopathy (oHCM) at the European
• Crypto Regulation Watch: New SEC Proposal Reshapes the Backdrop for September Presales as VOIDTRACE AI Prepares $VOIDE
• Windows Plus Backs Replacement Windows With Lifetime Warranty